|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.50 HKD | +0.06% |
|
-6.27% | -50.00% |
| 06-26 | Cf Pharmtech, Inc. Announces Board and Supervisor Appointments, Effective June 26, 2026 | CI |
| 06-05 | CF PharmTech Clears GMP Inspection for Suzhou Inhalation Drug Facility | MT |
| Market Cap | 6.22B 7.19B 917M 803M 740M 684M 1.3B 87.5B 1.32B 8.84B 3.47B 43.11B 3.44B 3.37B 148B | P/E 2024 * |
-
| P/E 2025 | 4,780x |
|---|---|---|---|---|---|
| Enterprise Value | 5.71B 6.6B 842M 737M 679M 628M 1.19B 80.32B 1.21B 8.12B 3.19B 39.57B 3.16B 3.09B 136B | EV / Sales 2024 * |
-
| EV / Sales 2025 | 28.8x |
| Free-Float |
33.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.06% | ||
| 1 week | -6.27% | ||
| Current month | -16.67% | ||
| 1 month | -5.66% | ||
| 3 months | -23.91% | ||
| 6 months | -44.27% | ||
| Current year | -50.00% |
| 1 week | 17 |  | 19.13 |
| 1 month | 16.96 | | 21.2 |
| Current year | 16.96 | | 39.5 |
| 1 year | 16.96 | | 48.8 |
| 3 years | 16.96 | | 48.8 |
| 5 years | 16.96 | | 48.8 |
| 10 years | 16.96 | | 48.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wen Qing Liang
CEO | Chief Executive Officer | 60 | 2006-12-31 |
Li Li
CTO | Chief Tech/Sci/R&D Officer | 67 | 2020-08-31 |
Wei Wei
DFI | Director of Finance/CFO | 47 | 2021-11-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Li Li
BRD | Director/Board Member | 67 | 2020-08-31 |
Wen Qing Liang
CHM | Chairman | 60 | 2006-12-31 |
Qi Li
BRD | Director/Board Member | 67 | 2020-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12-21 | Other | Chief Executive Officer | 6,500 | 0.0022% | ||
| 12-21 | Other | Founder | 6,500 | 0.0022% | ||
| 12-18 | Other | Chief Executive Officer | 5,000 | 0.0017% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.06% | -6.27% | - | - | 917M | |
| -2.33% | -2.09% | +50.33% | +162.29% | 1,060B | |
| -0.82% | -2.30% | +62.97% | +61.11% | 619B | |
| -0.73% | -4.98% | +27.22% | +84.46% | 438B | |
| +0.33% | -1.17% | +27.98% | +26.90% | 333B | |
| -0.02% | -2.85% | +25.27% | +44.88% | 282B | |
| -3.89% | -11.22% | +20.78% | +26.07% | 267B | |
| +0.66% | -1.42% | -29.26% | -39.30% | 218B | |
| -0.06% | -2.88% | +20.98% | +61.70% | 196B | |
| -3.72% | -1.10% | +13.35% | +71.53% | 161B | |
| Average | -0.80% | -3.55% | +24.40% | +55.51% | 357.48B | |
| Weighted average by Cap. | -0.56% | -2.96% | +35.28% | +81.27% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 608M 703M 89.63M 78.4M 72.32M 66.79M 127M 8.55B 129M 864M 339M 4.21B 337M 329M 14.48B | 433M 500M 63.79M 55.8M 51.47M 47.53M 90.19M 6.08B 91.71M 615M 241M 3B 240M 234M 10.3B |
| Net income | 21.09M 24.38M 3.11M 2.72M 2.51M 2.32M 4.4M 297M 4.47M 29.98M 11.77M 146M 11.68M 11.42M 502M | 2.48M 2.87M 366K 321K 296K 273K 518K 34.95M 527K 3.53M 1.39M 17.22M 1.38M 1.35M 59.2M |
| Net Debt | -275M -318M -40.56M -35.48M -32.72M -30.22M -57.35M -3.87B -58.31M -391M -154M -1.91B -152M -149M -6.55B | -511M -590M -75.31M -65.88M -60.76M -56.12M -106M -7.18B -108M -726M -285M -3.54B -283M -277M -12.16B |
Employees
540
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | HK$17.50 | +0.06% | 155,000 |
| 26-07-09 | HK$17.49 | +0.23% | 458,000 |
| 26-07-08 | HK$17.45 | +0.81% | 721,000 |
| 26-07-07 | HK$17.31 | -5.92% | 878,000 |
| 26-07-06 | HK$18.40 | -1.45% | 347,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2652 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
